target directory

allogeneic pancreatic endoderm cells pec211 genetically modified using crispr cas9 to promote immune evasiveness and survival clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.